Description
Buy pb-22 online – PB-22 Powder for sale
Buy pb-22 online. 1-pentyl-1H-indole-3-acid 8-quinolinyl ester) is a designer drug offered by online vendors as a cannabimimetic agent. And detected being sold in synthetic cannabis products in Japan in 2013. PB-22 Powder for sale
The structure of PB-22 appears to use an understanding of structure-activity relationships within the indole class of cannabimimetics. Even though its design origins are unclear. Also, PB-22 represents a structurally unique synthetic cannabinoid chemotype.
Also since it contains an ester linker at the indole 3-position, rather than the precedented ketone of JWH-018 and its analogs, or the amide of APICA and its analogs.
PB-22 (Item No. ISO00122) is an analytical reference material categorized as a synthetic cannabinoid. It mimics the effects of Δ9-THC (Item Nos. 12068 | ISO60157). More so, 1 PB-22 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications. PB-22 Formal Name: 1- pentyl- 8- quinolinyl ester- 1H- indole- 3- carboxylic acid CAS Number: 1400742-17-7 Molecular Formula: C23H22N2O2 Formula Weight: 358.4 Formulation: A crystalline solid Purity : ≥98%.
The construction of PB-22 seems to take advantage of an understanding of structure-activity interactions inside of the indole class of cannabimimetics. Even though its structure roots tend to be uncertain. PB-22 represents a structurally distinctive chemotype, considering that it incorporates an ester linker right at the indole 3-position, as opposed to the precedented ketone of as well as its analogs, or even the amide of SDB-001 together with its analogs.
Buy PB-22 Online, PB-22 (1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid) and 5F-PB-22 (1-(5-fluorophenyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid) are new synthetic cannabinoids with a quinoline substructure and the first marketed substances with an ester bond linkage. WARNING This product is not for human or veterinary use.
Reviews
There are no reviews yet.